Incidence of immune-related adverse events with pembrolizumab in advanced melanoma and correlation with treatment response: A single institution review of irAEs Meeting Abstract


Authors: Myrdal, C. N.; Mehta, P.; Smith, E.; Briones, K.; Albright, J.; Curiel-Lewandrowski, C.; McBride, A.; Sundararajan, S.
Abstract Title: Incidence of immune-related adverse events with pembrolizumab in advanced melanoma and correlation with treatment response: A single institution review of irAEs
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120305200
DOI: 10.1200/JCO.2021.39.15_suppl.e21519
PROVIDER: wos
Notes: Meeting Abstract: e21519 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paras Mehta
    14 Mehta